GNLX Genelux
Genelux earnings company data as of 7:59 AM ET 10/23
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | — | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 13 Aug | EPS | — | -0.21 | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by GNLX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- None no sales outside a trading plan
- $109K sold by 1 insider under 10b5-1 plans
-
John Thomas DirectorPlanned sale$30K 10,000 shares at $2.98 2.1% of stakeTraded Jun 1 Filed Jun 2
-
John Thomas DirectorPlanned sale$29K 10,000 shares at $2.90 2% of stakeTraded Mar 2 Filed Mar 3
-
John Thomas DirectorPlanned sale$50K 10,000 shares at $5.00 2% of stakeTraded Dec 1, 2025 Filed Dec 2, 2025
Also filed in the last 12 months, not counted as buying or selling: 22 sales to cover taxes and 9 stock grants.
SEC filings
Recent issuer filings from EDGAR, 12 shown.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.